Cortexin Research for Cognitive Impairment
An evidence-based overview of research examining Cortexin in the context of cognitive impairment. This page synthesizes findings from peer-reviewed literature.
Research Summary
Russian studies have evaluated Cortexin for age-related cognitive decline and dementia. Multicenter studies report improvements in memory and attention, particularly in elderly patients with chronic cerebral ischemia. Evidence quality is limited by study design and lack of independent replication.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Cognitive Impairment
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Cortexin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.